Position in TNYA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$490,434
+$173,010 QoQ
Shares Held
708,721
+59.0% QoQ
Ownership
0.327%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 103 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 62.5381497091239.ToString("F0")%
Shared 0.ToString("F0")%
None 37.4618502908761.ToString("F0")%
Common Shares in TNYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,293,175,602 across 421 Biotechnology names. TNYA ranks #297 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in TNYA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $490,434 | 708,721 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $317,424 | 445,821 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $722,230 | 445,821 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $128,200 | 209,821 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $641,393 | 1,125,252 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,577,421 | 1,103,092 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,043,673 | 1,058,898 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,253,115 | 1,049,392 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,069,423 | 969,297 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,978,279 | 919,222 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,241,610 | 879,063 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,826,302 | 822,198 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,415,880 | 496,800 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $858,454 | 427,092 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $1,173,818 | 404,765 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $2,198,075 | 390,422 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,479,682 | 295,389 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,075,595 | 215,071 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,765,259 | 182,337 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||